United States Cancer Biomarkers Market Report 2016

Publisher Name :
Date: 25-Oct-2016
No. of pages: 120
Inquire Before Buying

Notes:

Sales, means the sales volume of Cancer Biomarkers

Revenue, means the sales value of Cancer Biomarkers

This report studies sales (consumption) of Cancer Biomarkers in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Abbott Laboratories (U.S.)

- Affymetrix Inc. (U.S.)

- Roche Diagnostics Ltd. (Switzerland)

- Illumina, Inc. (U.S.)

- Qiagen NV (Netherlands)

- Agilent Technologies (U.S.)

- Thermo Fisher Scientific Inc. (U.S.)

- Merck & Co. Inc. (U.S.)

- Becton Dickinson and Company (U.S.)

- Hologic Inc. (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Protein Biomarkers

- Genetic Biomarkers

- Others

Split by applications, this report focuses on sales, market share and growth rate of Cancer Biomarkers in each application, can be divided into

- Diagnostics

- Drug Discovery and Development

- Prognostics

- Risk Assessment

- Others?

United States Cancer Biomarkers Market Report 2016

Table of Contents
United States Cancer Biomarkers Market Report 2016
1 Cancer Biomarkers Overview
1.1 Product Overview and Scope of Cancer Biomarkers
1.2 Classification of Cancer Biomarkers
1.2.1 Protein Biomarkers
1.2.2 Genetic Biomarkers
1.2.3 Others
1.3 Application of Cancer Biomarkers
1.3.1 Diagnostics
1.3.2 Drug Discovery and Development
1.3.3 Prognostics
1.3.4 Risk Assessment
1.3.5 Others?
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Biomarkers (2011-2021)
1.4.1 United States Cancer Biomarkers Sales and Growth Rate (2011-2021)
1.4.2 United States Cancer Biomarkers Revenue and Growth Rate (2011-2021)
2 United States Cancer Biomarkers Competition by Manufacturers
2.1 United States Cancer Biomarkers Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cancer Biomarkers Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cancer Biomarkers Average Price by Manufactures (2015 and 2016)
2.4 Cancer Biomarkers Market Competitive Situation and Trends
2.4.1 Cancer Biomarkers Market Concentration Rate
2.4.2 Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Cancer Biomarkers Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Cancer Biomarkers Sales and Market Share by Type (2011-2016)
3.2 United States Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
3.3 United States Cancer Biomarkers Price by Type (2011-2016)
3.4 United States Cancer Biomarkers Sales Growth Rate by Type (2011-2016)
4 United States Cancer Biomarkers Sales (Volume) by Application (2011-2016)
4.1 United States Cancer Biomarkers Sales and Market Share by Application (2011-2016)
4.2 United States Cancer Biomarkers Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Cancer Biomarkers Manufacturers Profiles/Analysis
5.1 Abbott Laboratories (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Cancer Biomarkers Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Abbott Laboratories (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Affymetrix Inc. (U.S.)
5.2.2 Cancer Biomarkers Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Affymetrix Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Roche Diagnostics Ltd. (Switzerland)
5.3.2 Cancer Biomarkers Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Illumina, Inc. (U.S.)
5.4.2 Cancer Biomarkers Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Illumina, Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Qiagen NV (Netherlands)
5.5.2 Cancer Biomarkers Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Qiagen NV (Netherlands) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Agilent Technologies (U.S.)
5.6.2 Cancer Biomarkers Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Agilent Technologies (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Thermo Fisher Scientific Inc. (U.S.)
5.7.2 Cancer Biomarkers Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Merck & Co. Inc. (U.S.)
5.8.2 Cancer Biomarkers Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Becton Dickinson and Company (U.S.)
5.9.2 Cancer Biomarkers Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Hologic Inc. (U.S.)
5.10.2 Cancer Biomarkers Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Hologic Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Cancer Biomarkers Manufacturing Cost Analysis
6.1 Cancer Biomarkers Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cancer Biomarkers
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Cancer Biomarkers Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Cancer Biomarkers Market Forecast (2016-2021)
10.1 United States Cancer Biomarkers Sales, Revenue Forecast (2016-2021)
10.2 United States Cancer Biomarkers Sales Forecast by Type (2016-2021)
10.3 United States Cancer Biomarkers Sales Forecast by Application (2016-2021)
10.4 Cancer Biomarkers Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Cancer Biomarkers
Table Classification of Cancer Biomarkers
Figure United States Sales Market Share of Cancer Biomarkers by Type in 2015
Figure Protein Biomarkers Picture
Figure Genetic Biomarkers Picture
Figure Others Picture
Table Application of Cancer Biomarkers
Figure United States Sales Market Share of Cancer Biomarkers by Application in 2015
Figure Diagnostics Examples
Figure Drug Discovery and Development Examples
Figure Prognostics Examples
Figure Risk Assessment Examples
Figure Others? Examples
Figure United States Cancer Biomarkers Sales and Growth Rate (2011-2021)
Figure United States Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Table United States Cancer Biomarkers Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Biomarkers Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Biomarkers Sales Share by Manufacturers
Figure 2016 Cancer Biomarkers Sales Share by Manufacturers
Table United States Cancer Biomarkers Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 United States Cancer Biomarkers Revenue Share by Manufacturers
Table United States Market Cancer Biomarkers Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Biomarkers Average Price of Key Manufacturers in 2015
Figure Cancer Biomarkers Market Share of Top 3 Manufacturers
Figure Cancer Biomarkers Market Share of Top 5 Manufacturers
Table United States Cancer Biomarkers Sales by Type (2011-2016)
Table United States Cancer Biomarkers Sales Share by Type (2011-2016)
Figure United States Cancer Biomarkers Sales Market Share by Type in 2015
Table United States Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
Table United States Cancer Biomarkers Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Biomarkers by Type (2011-2016)
Table United States Cancer Biomarkers Price by Type (2011-2016)
Figure United States Cancer Biomarkers Sales Growth Rate by Type (2011-2016)
Table United States Cancer Biomarkers Sales by Application (2011-2016)
Table United States Cancer Biomarkers Sales Market Share by Application (2011-2016)
Figure United States Cancer Biomarkers Sales Market Share by Application in 2015
Table United States Cancer Biomarkers Sales Growth Rate by Application (2011-2016)
Figure United States Cancer Biomarkers Sales Growth Rate by Application (2011-2016)
Table Abbott Laboratories (U.S.) Basic Information List
Table Abbott Laboratories (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Affymetrix Inc. (U.S.) Basic Information List
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Basic Information List
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Qiagen NV (Netherlands) Basic Information List
Table Qiagen NV (Netherlands) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qiagen NV (Netherlands) Cancer Biomarkers Sales Market Share (2011-2016)
Table Agilent Technologies (U.S.) Basic Information List
Table Agilent Technologies (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Merck & Co. Inc. (U.S.) Basic Information List
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Becton Dickinson and Company (U.S.) Basic Information List
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Hologic Inc. (U.S.) Basic Information List
Table Hologic Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hologic Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Biomarkers
Figure Manufacturing Process Analysis of Cancer Biomarkers
Figure Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Cancer Biomarkers
Table Distributors/Traders List
Figure United States Cancer Biomarkers Production and Growth Rate Forecast (2016-2021)
Figure United States Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Table United States Cancer Biomarkers Production Forecast by Type (2016-2021)
Table United States Cancer Biomarkers Consumption Forecast by Application (2016-2021)
  • Global Biomarkers Market Size, Status and Forecast 2022
    Published: 18-Aug-2017        Price: US 3300 Onwards        Pages: 95
    This report studies the global Biomarkers market, analyzes and researches the Biomarkers development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Roche Diagnostic - Siemens Healthcare - Abbott Laboratories - Thermo Fisher Scientific - Agilent Technologies - Bio-Rad Laboratories - Aushon BioSystem - Epistem Ltd - Affymetrix......
  • Global Biomarkers Market Research Report 2017
    Published: 18-Aug-2017        Price: US 2900 Onwards        Pages: 114
    In this report, the global Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biomarkers in these regions, from 2012 to 2022 (forecast), covering - United States - EU - China - Japan - So......
  • Asia-Pacific Cancer Biomarker Market 2017-2025
    Published: 16-Aug-2017        Price: US 1250 Onwards        Pages: 75
    Key Findings The Asia-Pacific cancer biomarkers market is expected to speed up its growth with a CAGR of 15.73% for the years 2017-2025, generating a net worth of $8831 million. India is the fastest growing market in the Asia-Pacific region. Market Insights The market is mainly categorized into diseases and discovery & diagnostics, and further into their sub-segments. The adoption of western lifestyles in developing Asia Pacific regions, prevailing high population, a......
  • Europe Cancer Biomarker Market Forecast 2017-2025
    Published: 16-Aug-2017        Price: US 1250 Onwards        Pages: 75
    Key Findings The Europe cancer biomarker market is poised to grow at a CAGR of 13.46% for the years 2017-2025. The total income generated by the market is also predicted to increase to up to $8646 million by the end of this forecast period. Market Insights The European market has a huge opportunity to grow in personalized medication on account of the support generated for the biomarkers test, growing medical tourism, and the rising number of cancer patients in the region. Al......
  • North America Cancer Biomarker Market Forecast 2017-2025
    Published: 16-Aug-2017        Price: US 1250 Onwards        Pages: 78
    Key Findings The United States is a primary contributor to the North American cancer biomarker market, which is all set to expand with a CAGR of 13.17% between the forecasted years of 2017-2025. The market collections are also predicted to increase from $3748 million in 2016 to $11420 million by 2025. Market Insights The market is mainly segmented into two segments: discovery& diagnostics and diseases. These two are further divided into multiple sub-segments. The huge invest......
  • Global Cancer Biomarker Market Forecast 2017-2025
    Published: 16-Aug-2017        Price: US 2500 Onwards        Pages: 145
    Key Findings The global cancer biomarker market is expected to grow at a CAGR of 14.07% between the years 2017- 2025, generating a net worth of $33026 million by the end of 2025. Some of the important drivers for the global biomarker market include encouragement by the FDA for biomarker development, the adoption of western lifestyles in developing countries, heavy investments by government and private funds for cancer-related research, etc. At present, the genetic and genomic biomarkers a......
  • 2017-2022 Global and Japan Circulating Biomarker Market Analysis Report
    Published: 16-Aug-2017        Price: US 3085 Onwards        Pages: 101
    The global Circulating Biomarker market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%. This report, with focus on top players in the global and Japan, studies the Circulating Biomarker market's development status and future tr......
  • Global Circulating Biomarker Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
    Published: 16-Aug-2017        Price: US 2380 Onwards        Pages: 100
    The global Circulating Biomarker market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. This report offers an overview of the market trends, drivers, and barriers with respect to the Circulating Biomarker market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Cir......
  • Global and United States Circulating Biomarker In-Depth Research Report 2017-2022
    Published: 16-Aug-2017        Price: US 3190 Onwards        Pages: 101
    The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Circulating Biomarker industry. Major Companies Biocept Inc (U.S.) Myriad Genetics (U.S......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs